ePrivacy and GPDR Cookie Consent by Cookie Consent

PRESS RELEASE: Agreement to file a friendly takeover bid initiated by OncoDNA on IntegraGen to acquire all outstanding shares at a price of 2.20€ per share


July 9, 2020


Gosselies, Belgium – Évry, France July 9th, 2020
This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.


Download PDF    Download the Information Note (FRENCH)